We need to sell or provide this tech worldwide, except probably in countries where it is too dangerous to set foot to sell. There are as many or even more sick people in Asia, Africa, South America, Japan, and New Zealand. As I mentioned in my previous posts before, I happened to go to a few hospitals in a third world country last year and saw that good hospitals there do already have the latest state of the art technologies, and many of their medical professionals do practice in Europe and the US. I don't think it is unusual for top notch Japanese or Filipino doctors to spend a few months a year in the US treating patients and they're exposed to or need the aid of the latest and fastest tech. Every lab needs APAS. That's what Lbt has put in the preso, the numbe of small, medium and large labs
globally as its target market. So the question is, has LBT applied for similar approval in those countries?
View attachment 524103
